{"content":"<li class=\"n-box-item date-title\" data-end=\"1433217599\" data-start=\"1433131200\" data-txt=\"Sunday, December 22, 2019\">Monday, June  1, 2015</li><li class=\"n-box-item sa-box-item\" data-id=\"2555866\" data-ts=\"1433207334\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTDOY\" target=\"_blank\">NTDOY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2555866-rumor-of-nintendo-going-android-based-not-the-worst-idea\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rumor of Nintendo going Android-based: Not the worst idea?</a></h4><ul>   <li>It's a thin rumor, fed by the secrecy around Nintendo's (<a href=\"https://seekingalpha.com/symbol/NTDOY\" title=\"Nintendo Co., Ltd. ADR\">OTCPK:NTDOY</a> <font color=\"green\">+1.9%</font>) upcoming \"NX\" console/platform, but a <a href=\"https://translate.google.com/translate?sl=auto&amp;tl=en&amp;js=y&amp;prev=_t&amp;hl=en&amp;ie=UTF-8&amp;u=www.nikkei.com%2Farticle%2FDGXMZO87370000Y5A520C1000000%2F&amp;edit-text=\" target=\"_blank\">column</a> in <i>Nikkei Shimbun</i> suggests the company could base the system on Google's Android OS.</li>    <li>That would be a stark change for a company with tight control over software and OS development, but it's building up some <a href=\"http://www.theverge.com/2015/6/1/8696979/nintendo-nx-android-is-a-good-idea\" target=\"_blank\">media support</a> today: Users are familiar with a <a href=\"http://time.com/3903410/nintendo-android/\" target=\"_blank\">slow Wii U interface</a> that could benefit from a speed injection, and there's a case to be made for stronger <a href=\"http://business.financialpost.com/fp-tech-desk/post-arcade/why-a-nintendo-box-built-around-android-is-actually-a-really-good-idea\" target=\"_blank\">third-party development</a> support.</li>    <li>Nintendo would likely pursue an Android fork where it wouldn't have to share a cut of game sales with Google (which would surely be a dealbreaker), and -- again due to its tight grip -- would be able to strictly manage a consistent look and feel.</li>    <li>As for whether ceding OS development is too much of a culture shock for the company, it did break another barrier this spring by paving the way for its <a href=\"https://seekingalpha.com/news/2372866\" target=\"_blank\">games to go mobile</a> (and thus to other hardware).</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2508256-nintendos-mobile-plan-five-games-by-march-2017\" target=\"_blank\">Nintendo's mobile plan: Five games by March 2017</a> (May. 08 2015)</li> </ul><div class=\"tiny-share-widget\" data-id=\"2555866\" data-linked=\"Rumor of Nintendo going Android-based: Not the worst idea?\" data-tweet=\"$NTDOY - Rumor of Nintendo going Android-based: Not the worst idea? https://seekingalpha.com/news/2555866-rumor-of-nintendo-going-android-based-not-the-worst-idea?source=tweet\" data-url=\"https://seekingalpha.com/news/2555866-rumor-of-nintendo-going-android-based-not-the-worst-idea\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2555766\" data-ts=\"1433198157\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TUBE\" target=\"_blank\">TUBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2555766-tubemogul-down-8_9-percent-in-late-trade-on-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TubeMogul down 8.9% in late trade on share offering</a></h4><ul>   <li>TubeMogul (NASDAQ:<a href=\"https://seekingalpha.com/symbol/TUBE\" title=\"TubeMogul\">TUBE</a>) is <font color=\"red\">off 8.9%</font> after hours as it's <a href=\"http://yahoo.brand.edgar-online.com/EFX_dll/EDGARpro.dll?FetchFilingHtmlSection1?SectionID=10737929-769-843632&amp;SessionID=28E9ee9tsQBP-Z2\" target=\"_blank\">filed an S-1</a> relating to a proposed public share offering.</li>    <li>The company says a portion of the shares to be sold would be by TubeMogul and a portion by existing stockholders (for which TubeMogul wouldn't receive any proceeds).</li>    <li>J.P. Morgan, BofA Merrill Lynch and Citigroup are acting as joint book runners.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2555766\" data-linked=\"TubeMogul down 8.9% in late trade on share offering\" data-tweet=\"$TUBE - TubeMogul down 8.9% in late trade on share offering https://seekingalpha.com/news/2555766-tubemogul-down-8_9-percent-in-late-trade-on-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/2555766-tubemogul-down-8_9-percent-in-late-trade-on-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2555696\" data-ts=\"1433195902\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTW\" target=\"_blank\">MTW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2555696-manitowoc-rises-as-glenview-capital-discloses-7_06-percent-active-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Manitowoc rises as Glenview Capital discloses 7.06% active stake</a></h4><ul>     <li>Manitowoc (NYSE:<a href='https://seekingalpha.com/symbol/MTW' title='Manitowoc Company, Inc.'>MTW</a>) <font color='green'>+2.7%</font>&nbsp;AH after hedge fund Glenview Capital <a href=\"https://www.sec.gov/Archives/edgar/data/61986/000090514815000565/efc15-450_sc13d.htm\" target=\"_blank\">discloses a 7.06% active stake</a> totaling more than 9.6M shares in the company, up from the more than 8.6M shares held as of March 31.</li>     <li>Larry Robbins' fund says it may discuss with MTW options for exploring alternatives that could enhance shareholder value.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2555696\" data-linked=\"Manitowoc rises as Glenview Capital discloses 7.06% active stake\" data-tweet=\"$MTW - Manitowoc rises as Glenview Capital discloses 7.06% active stake https://seekingalpha.com/news/2555696-manitowoc-rises-as-glenview-capital-discloses-7_06-percent-active-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/2555696-manitowoc-rises-as-glenview-capital-discloses-7_06-percent-active-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2555666\" data-ts=\"1433194743\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2555666-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/AVEO' title='AVEO Pharmaceuticals, Inc.'>AVEO</a> <font color='green'>+3.1%</font>. <a href='https://seekingalpha.com/symbol/MDVN' title='Medivation, Inc.'>MDVN</a> <font color='green'>+3.1%</font>. <a href='https://seekingalpha.com/symbol/XOOM' title='Xoom, Inc.'>XOOM</a> <font color='green'>+2.3%</font>. <a href='https://seekingalpha.com/symbol/OCLR' title='Oclaro, Inc.'>OCLR</a> <font color='green'>+1.9%</font>. <a href='https://seekingalpha.com/symbol/CDXS' title='Codexis, Inc.'>CDXS</a> <font color='green'>+1.7%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/TUBE' title='TubeMogul'>TUBE</a> <font color='red'>-8.9%</font>. <a href='https://seekingalpha.com/symbol/QUNR' title='Qunar Cayman Islands Limited'>QUNR</a> <font color='red'>-3.6%</font>. FLML <font color='red'>-3.4%</font>. <a href='https://seekingalpha.com/symbol/UEPS' title='Net 1 UEPS Technologies, Inc.'>UEPS</a> <font color='red'>-3.2%</font>. CERU <font color='red'>-2.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2555666\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$AVEO $MDVN $XOOM - After Hours Gainers / Losers https://seekingalpha.com/news/2555666-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/2555666-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2555586\" data-ts=\"1433192982\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FGP\" target=\"_blank\">FGP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2555586-ferrellgas-partners-to-launch-6_325m-unit-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ferrellgas Partners to launch 6.325M-unit offering</a></h4><ul>     <li>Ferrellgas Partners (NYSE:<a href=\"https://seekingalpha.com/symbol/FGP\" title=\"Ferrellgas Partners L.P\">FGP</a>) <font color=\"red\">-3.2%</font> AH after announcing a public offering of 6.235M common units, with an underwriters option to purchase up to an additional 948,750 units.</li>     <li>FGP says it plans to use the proceeds to fund part of its <a href=\"https://seekingalpha.com/news/2553366-ferrellgas-to-buy-bridger-logistics-in-837_5m-deal\" target=\"_blank\">pending acquisition</a> of Bridger Logistics.</li>     <li>FGP also says its operating subsidiary will offer $400M in aggregate principal amount of senior unsecured notes due 2023 in a private placement.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2555586\" data-linked=\"Ferrellgas Partners to launch 6.325M-unit offering\" data-tweet=\"$FGP - Ferrellgas Partners to launch 6.325M-unit offering https://seekingalpha.com/news/2555586-ferrellgas-partners-to-launch-6_325m-unit-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/2555586-ferrellgas-partners-to-launch-6_325m-unit-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2555546\" data-ts=\"1433192415\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BXMT\" target=\"_blank\">BXMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2555546-blackstone-mortgage-trust-minus-2_1-percent-after-another-capital-raise\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blackstone Mortgage Trust -2.1% after another capital raise</a></h4><ul>\n<li>Blackstone Mortgage Trust (NYSE:<a href=\"https://seekingalpha.com/symbol/BXMT\" title=\"Blackstone Mortgage Trust, Inc.\">BXMT</a>) announces a 10M share secondary offering with underwriter greenshoe of another 1.5M shares.</li>\n<li>The company six weeks ago <a href=\"https://seekingalpha.com/news/2424096-blackstone-mortgage-trust-upsizes-and-prices-secondary\" target=\"_blank\">sold 20M shares</a> to help raise funds for its purchase of a commercial loan portfolio from GE Capital.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2555546\" data-linked=\"Blackstone Mortgage Trust -2.1% after another capital raise\" data-tweet=\"$BXMT - Blackstone Mortgage Trust -2.1% after another capital raise https://seekingalpha.com/news/2555546-blackstone-mortgage-trust-minus-2_1-percent-after-another-capital-raise?source=tweet\" data-url=\"https://seekingalpha.com/news/2555546-blackstone-mortgage-trust-minus-2_1-percent-after-another-capital-raise\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2555386\" data-ts=\"1433190347\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DMDA\" target=\"_blank\">DMDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2555386-dex-media-up-34-percent-for-second-day-of-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dex Media up 34% for second day of gains</a></h4><ul>   <li>More gains on high volume for Dex Media (DXM), <font color=\"green\">up 34.5%</font> today, building on Friday's <font color=\"green\">15.4% gain</font>. There no notable news on the stock.</li>    <li>To put the gains in perspective, it's coming off a 52-week low or $0.67 on Friday morning and has still <font color=\"red\">lost 87.2%</font> of value YTD. Shares traded at $8.81 on Jan. 2.</li>    <li>After crumbling on a <a href=\"https://seekingalpha.com/news/2501276-dex-media-crumbles-53-percent-on-heavy-q1-loss\" target=\"_blank\">rough Q1 report</a> last month, emphasis was on fixing the sales side of the operation, as its sales chief had resigned and revenues dropped 11%.</li>    <li>Short percentage of float at April's end was 42%, with prior-month shares up to 5.29M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2555386\" data-linked=\"Dex Media up 34% for second day of gains\" data-tweet=\"$DMDA - Dex Media up 34% for second day of gains https://seekingalpha.com/news/2555386-dex-media-up-34-percent-for-second-day-of-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/2555386-dex-media-up-34-percent-for-second-day-of-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2555346\" data-ts=\"1433189844\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVH\" target=\"_blank\">PVH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2555346-new-buyback-and-positive-underlying-comps-lift-pvh-corp\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New buyback and positive underlying comps lift PVH Corp.</a></h4><ul>\n<li>PVH Corp. (NYSE:<a href=\"https://seekingalpha.com/symbol/PVH\" title=\"PVH Corp.\">PVH</a>) reports revenue was up 5% for the Calvin Klein business and 1% for Tommy Hilfiger in Q1 on a constant currency basis.</li>\n<li>The North America retail store comp was -1% for Calvin Klein  and -3% for Tommy Hilfiger as a strong U.S. dollar held back international tourist spending.</li>\n<li>The company says it authorized a new $500M buyback program.</li>\n<li>Guidance: PVH expects full-years EPS of $6.85-$6.95 vs. $6.86 consensus.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2555276-phillips-van-heusen-beats-by-0_12-beats-on-revenue\" target=\"_blank\">Phillips-Van Heusen beats by $0.12, beats on revenue</a> (June 1)</li>\n<li>PVH +2.41% after hours.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2555346\" data-linked=\"New buyback and positive underlying comps lift PVH Corp.\" data-tweet=\"$PVH - New buyback and positive underlying comps lift PVH Corp. https://seekingalpha.com/news/2555346-new-buyback-and-positive-underlying-comps-lift-pvh-corp?source=tweet\" data-url=\"https://seekingalpha.com/news/2555346-new-buyback-and-positive-underlying-comps-lift-pvh-corp\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2555276\" data-ts=\"1433188941\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PVH\" target=\"_blank\">PVH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2555276-phillips-van-heusen-beats-by-0_12-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Phillips-Van Heusen beats by $0.12, beats on revenue</a></h4><ul>\n<li>Phillips-Van Heusen (NYSE:<a href=\"https://seekingalpha.com/symbol/PVH\" title=\"PVH Corp.\">PVH</a>): Q1 EPS of $1.50 <font color=\"green\">beats by $0.12</font>.</li>\n<li>Revenue of $1.88B (-4.1% Y/Y) <font color=\"green\">beats by $20M</font>.</li>\n<li>Shares <font color=\"green\">+2%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2555276\" data-linked=\"Phillips-Van Heusen beats by $0.12, beats on revenue\" data-tweet=\"$PVH - Phillips-Van Heusen beats by $0.12, beats on revenue https://seekingalpha.com/news/2555276-phillips-van-heusen-beats-by-0_12-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/2555276-phillips-van-heusen-beats-by-0_12-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2555226\" data-ts=\"1433188616\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LUV\" target=\"_blank\">LUV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2555226-southwest-ceo-pulls-up-airline-sector-with-comments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Southwest CEO pulls up airline sector with comments</a></h4><ul>     <li>Southwest Airlines (<a href='https://seekingalpha.com/symbol/LUV' title='Southwest Airlines Co.'>LUV</a> <font color='green'>+2.3%</font>) CEO Gary Kelly brought some cheer to the airline sector when he told Bloomberg TV it will <a href=\"http://www.bloomberg.com/news/articles/2015-06-01/southwest-to-cap-seat-capacity-growth-at-7-raise-capital-goal\" target=\"_blank\">increase capacity</a> this year at a 7% rate - instead of the 8% pace tipped off last month.</li>     <li>\"We&rsquo;re going to make sure we manage accordingly to the low end of the range. That should address some of the concerns of our investors,&rdquo; said Kelly.</li><li>Alaska Air Group (<a href='https://seekingalpha.com/symbol/ALK' title='Alaska Air Group, Inc.'>ALK</a> <font color='green'>+2.2%</font>), American Airlines Group (<a href='https://seekingalpha.com/symbol/AAL' title='American Airlines Group'>AAL</a> <font color='green'>+4.3%</font>), Delta Air Lines (<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a> <font color='green'>+3.4%</font>), and United Continental (<a href='https://seekingalpha.com/symbol/UAL' title='United Continental Holdings, Inc'>UAL</a> <font color='green'>+3.2%</font>) all reacted positively to the cautious stance from Southwest.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2555226\" data-linked=\"Southwest CEO pulls up airline sector with comments\" data-tweet=\"$LUV $LUV $ALK - Southwest CEO pulls up airline sector with comments https://seekingalpha.com/news/2555226-southwest-ceo-pulls-up-airline-sector-with-comments?source=tweet\" data-url=\"https://seekingalpha.com/news/2555226-southwest-ceo-pulls-up-airline-sector-with-comments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2555196\" data-ts=\"1433188067\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATNM\" target=\"_blank\">ATNM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2555196-investors-underwhelmed-with-25-percent-response-rate-for-actinium-pharmas-actimab-a\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors underwhelmed with 25% response rate for Actinium Pharma&#39;s Actimab-A</a></h4><ul>\n<li>Actinium Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/ATNM\" title=\"Actinium Pharmaceuticals, Inc.\">ATNM</a> <font color=\"red\">-19%</font>) slumps on a 4x surge in volume in response to its abstract (#<a href=\"http://abstracts.asco.org/156/AbstView_156_148383.html\" target=\"_blank\">7050</a>) and poster on Actimab-A that was presented yesterday at ASCO.</li>\n<li>In a Phase 1/2 study in elderly patients with newly diagnosed acute myeloid leukemia, subjects treated with Actimab-A showed an overall response rate of only 25% (n=3/12), but 67% (n=2/3) in those treated with the highest dose (1.5 uCi/kg/fraction).</li>\n<li>A fourth cohort at a dose 33% higher (2.0) began recently.</li>\n<li>\n<a href=\"http://www.actiniumpharma.com/products/pipeline/actimab-a/\" target=\"_blank\">Actimab-A</a> is a monoclonal antibody with an attached radioisotope (Actinium 225) that binds to cancer cells thereby delivering radiotherapy directly to the cancer.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2555196\" data-linked=\"Investors underwhelmed with 25% response rate for Actinium Pharma&#39;s Actimab-A\" data-tweet=\"$ATNM - Investors underwhelmed with 25% response rate for Actinium Pharma&#39;s Actimab-A https://seekingalpha.com/news/2555196-investors-underwhelmed-with-25-percent-response-rate-for-actinium-pharmas-actimab-a?source=tweet\" data-url=\"https://seekingalpha.com/news/2555196-investors-underwhelmed-with-25-percent-response-rate-for-actinium-pharmas-actimab-a\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2555166\" data-ts=\"1433186679\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTU\" target=\"_blank\">BTU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2555166-peabody-energy-cloud-peak-sink-on-negative-goldman-sachs-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Peabody Energy, Cloud Peak sink on negative Goldman Sachs view</a></h4><ul>     <li>Peabody Energy (<a href=\"https://seekingalpha.com/symbol/BTU\" title=\"Peabody Energy Corp.\">BTU</a> <font color=\"red\">-9%</font>) and Cloud Peak Energy (<a href=\"https://seekingalpha.com/symbol/CLD\" title=\"Cloud Peak Energy, Inc.\">CLD</a> <font color=\"red\">-9.3%</font>) are sharply lower after Goldman Sachs <a href=\"http://blogs.barrons.com/stockstowatchtoday/2015/06/01/coal-big-gains-to-be-had-just-not-in-peabody-energy/\" target=\"_blank\">recommends investors sell shares</a>, seeing BTU as something of a proxy for its bearish view on met coal prices - which the firm expects to remain pressured through 2017 - and CLD as a pure-play exposure to Powder River Basin thermal coal.</li>     <li>However, the firm sees \"idiosyncratic opportunities\" for substantial gains in the  coal sector, identifying Illinois Basin thermal coal as the one thermal coal segment where fundamentals are not negative and naming Foresight Energy (<a href=\"https://seekingalpha.com/symbol/FELP\" title=\"Foresight Energy LP\">FELP</a> <font color=\"green\">+3.5%</font>) a Buy for its pure-play exposure to the IB and attractive drop-down potential following the recent Murray Energy transaction.</li>     <li>Goldman also maintains its Buy rating on SunCoke Energy (<a href=\"https://seekingalpha.com/symbol/SXC\" title=\"SunCoke Energy\">SXC</a> <font color=\"red\">-1.2%</font>) given low-cost, organic growth from dropdowns, a strong balance sheet  that improves prospects of inorganic growth and attractive valuation.</li>     <li>The firm also maintains its Neutral rating on Arch Coal (<a href=\"https://seekingalpha.com/symbol/ACI\" title=\"Albertsons Companies Inc\">ACI</a> <font color=\"green\">+2.8%</font>) while upgrading Alpha Natural Resources (ANR <font color=\"green\">+2.6%</font>) to Neutral from Sell.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2555166\" data-linked=\"Peabody Energy, Cloud Peak sink on negative Goldman Sachs view\" data-tweet=\"$BTU $BTU $CLDPQ - Peabody Energy, Cloud Peak sink on negative Goldman Sachs view https://seekingalpha.com/news/2555166-peabody-energy-cloud-peak-sink-on-negative-goldman-sachs-view?source=tweet\" data-url=\"https://seekingalpha.com/news/2555166-peabody-energy-cloud-peak-sink-on-negative-goldman-sachs-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2555126\" data-ts=\"1433185913\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GSAT\" target=\"_blank\">GSAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2555126-globalstar-slides-12_6-percent-as-microsoft-urges-rejection-of-technology\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Globalstar slides 12.6% as Microsoft urges rejection of technology</a></h4><ul>   <li>Globalstar (NYSEMKT:<a href=\"https://seekingalpha.com/symbol/GSAT\" title=\"Globalstar, Inc.\">GSAT</a>) is <font color=\"red\">off 12.6%</font> today -- giving back strong Friday gains and then some -- as Microsoft is urging the FCC to reject Globalstar's key Terrestrial Low Power Service (TLPS) technology.</li>    <li>In an <a href=\"http://apps.fcc.gov/ecfs/comment/view?id=60001059552\" target=\"_blank\">ex parte filing</a> made public today, Microsoft pointed to its agreement with the Consumer Electronics Association, which urged deferring approval until \"comprehensive, open and transparent\" testing of TLPS to ensure it didn't interfere with Bluetooth, Wi-Fi and other adjacent spectrum.</li>    <li>\"Disappointingly, the record has shown that Globalstar has chosen not to take such actions,\" Microsoft says.</li>    <li>Microsoft expressed concern about interference with game consoles like the Xbox (which rely extensively on the 2.4 GHz band), and that Globalstar could switch to LTE from an 802.11 standard, which could risk substantially more interference than demonstrated.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2555126\" data-linked=\"Globalstar slides 12.6% as Microsoft urges rejection of technology\" data-tweet=\"$GSAT - Globalstar slides 12.6% as Microsoft urges rejection of technology https://seekingalpha.com/news/2555126-globalstar-slides-12_6-percent-as-microsoft-urges-rejection-of-technology?source=tweet\" data-url=\"https://seekingalpha.com/news/2555126-globalstar-slides-12_6-percent-as-microsoft-urges-rejection-of-technology\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2554886\" data-ts=\"1433184114\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CZR\" target=\"_blank\">CZR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2554886-caesars-entertainment-minus-14-percent-as-investors-digest-court-developments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caesars Entertainment -14% as investors digest court developments</a></h4><ul> <li>Caesars Entertainment (<a href=\"https://seekingalpha.com/symbol/CZR\" title=\"Caesars Entertainment\">CZR</a> <font color=\"red\">-13.7%</font>) is down sharply after a <a href=\"http://www.bloomberg.com/news/articles/2015-05-29/caesars-latest-court-loss-adds-pressure-to-meet-with-creditors\" target=\"_blank\">court ruling</a> from late last week is viewed by investors as going in favor of bondholders.</li> <li>The development could force Caesars to negotiate better terms for senior and junior bond holders.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"2554886\" data-linked=\"Caesars Entertainment -14% as investors digest court developments\" data-tweet=\"$CZR - Caesars Entertainment -14% as investors digest court developments https://seekingalpha.com/news/2554886-caesars-entertainment-minus-14-percent-as-investors-digest-court-developments?source=tweet\" data-url=\"https://seekingalpha.com/news/2554886-caesars-entertainment-minus-14-percent-as-investors-digest-court-developments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2554876\" data-ts=\"1433183813\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPCB\" target=\"_blank\">SPCB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2554876-supercom-plus-11_2-percent-after-q1-report-guidance-reiterated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SuperCom +11.2% after Q1 report; guidance reiterated</a></h4><ul>\n<li>SuperCom (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SPCB\" title=\"SuperCom, Ltd.\">SPCB</a>) has blasted off after posting nearly in-line Q1 results and reiterating its 2015 guidance (40%+ revenue growth, EPS above $1.20). Shares currently trade at 10x a 2015 EPS consensus of $1.21.</li>\n<li>Positive <a href=\"https://twitter.com/GeoInvesting/status/605392976169177088\" target=\"_blank\">CC remarks</a> about deal activity are likely providing a lift; management stated it has been selected as a bidder of choice for contracts from multiple governments. An <a href=\"https://seekingalpha.com/news/2443566-supercom-up-10-percent-over-last-two-days-on-kenyan-deal-hopes\" target=\"_blank\">April report</a> from Security Document World fueled hopes SuperCom will win a deal to manage registration for Kenya's National Digital Registry Service.</li>\n<li>CEO Arie Trablesi in the earnings release: \"During [Q1], we have started to integrate our suite of secure payments solutions into existing e-ID contracts and continue to actively pursue large opportunities with organizations around the world ... We are increasingly excited about our pipeline of opportunities, which continued to grow as we advanced a number of important tenders during the quarter.\"</li>\n<li>\n<strong>Financials: </strong>Q1 gross margin was 70.1%, up slightly from Q4's 69.4% and down from Q1 2014's 80.7%. GAAP operating expenses fell 4% Y/Y to $2.79M - sales/marketing spend totaled $1.4M, R&amp;D $67&amp;K, and G&amp;A $716K. SuperCom ended Q1 with $4.2M in cash, $4.5M in restricted bank deposits, and no debt.</li>\n<li>\n<a href=\"https://seekingalpha.com/news/2553416-supercom-eps-in-line-beats-on-revenue\" target=\"_blank\">Q1 results</a>, PR</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2554876\" data-linked=\"SuperCom +11.2% after Q1 report; guidance reiterated\" data-tweet=\"$SPCB - SuperCom +11.2% after Q1 report; guidance reiterated https://seekingalpha.com/news/2554876-supercom-plus-11_2-percent-after-q1-report-guidance-reiterated?source=tweet\" data-url=\"https://seekingalpha.com/news/2554876-supercom-plus-11_2-percent-after-q1-report-guidance-reiterated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2554736\" data-ts=\"1433182589\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMBA\" target=\"_blank\">AMBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2554736-ambarella-plus-5-percent-after-gopro-camera-launch-earnings-due-tomorrow\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ambarella +5% after GoPro camera launch; earnings due tomorrow</a></h4><ul>\n<li>Ambarella (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AMBA\" title=\"Ambarella\">AMBA</a>) has surged to new highs yet again after GoPro (<font color=\"green\">up 6.7%</font>) <a href=\"https://seekingalpha.com/news/2554036-gopro-plus-3_8-percent-300-hero-camera-launched\" target=\"_blank\">unveiled the HERO+</a>, a $300 camera (presumably powered by an Ambarella video processor) sporting a touchscreen LCD, Wi-Fi/Bluetooth connectivity, and 60fps 1080p video recording. The camera is priced below the $400 HERO4 Silver and $500 HERO4 Black, and above the $130 entry-level HERO.</li>\n<li>Shares are now <strong><font color=\"green\">up 66%</font></strong> YTD, and trade for 33x an FY17 (ends Jan. '17) EPS consensus of $2.86 (estimates have been gradually rising). FQ1 results arrive tomorrow afternoon.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2554736\" data-linked=\"Ambarella +5% after GoPro camera launch; earnings due tomorrow\" data-tweet=\"$AMBA - Ambarella +5% after GoPro camera launch; earnings due tomorrow https://seekingalpha.com/news/2554736-ambarella-plus-5-percent-after-gopro-camera-launch-earnings-due-tomorrow?source=tweet\" data-url=\"https://seekingalpha.com/news/2554736-ambarella-plus-5-percent-after-gopro-camera-launch-earnings-due-tomorrow\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2554626\" data-ts=\"1433182107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2554626-linkedin-up-3_5-percent-amid-activist-rumor-bullish-rbc-note\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LinkedIn up 3.5% amid activist rumor, bullish RBC note</a></h4><ul>\n<li>An unconfirmed rumor (picked up by Briefing.com) that activist investors are taking stakes in LinkedIn (LNKD) appears to be lifting shares.</li>\n<li>Also possibly helping: <a href=\"http://blogs.barrons.com/techtraderdaily/2015/06/01/linkedin-lifted-by-activist-chatter-rbc-positive-after-mgmt-meetings/\" target=\"_blank\">A bullish note</a> from RBC's Mark Mahaney (Outperform, $275 target) that follows meetings with sales, content, and IR execs. Among other things, Mahaney reports LinkedIn: 1) Is \"very confident that engagement is rising.\" 2) Sees an $8B-$15B/year market opportunity for its <a href=\"https://business.linkedin.com/sales-solutions\" target=\"_blank\">Sales Solutions</a> (social selling) product. 3) Is upbeat about its ability to cross-sell <a href=\"https://seekingalpha.com/news/2417506-linkedin-buying-online-learning-platform-lynda-com-for-1_5b\" target=\"_blank\">Lynda.com's</a> online learning offerings to 37K HR units within organizations. 4) Is (notably) \"seeing a rebound in productivity trends\" following a Q1 Talent Solutions salesforce reorg.</li>\n<li>LinkedIn is a month removed from plunging due to the Q2/2015 guidance provided with its Q1 beat. The outlook <a href=\"https://seekingalpha.com/news/2476156-linkedin-minus-23_9-percent-weak-guidance-blamed-on-forex-ads-job-services-lynda-com\" target=\"_blank\">was blamed</a> on the reorg, a strong dollar, soft ad sales, and the impact of piloting different approaches to cross-selling Lynda.com services. Many analysts <a href=\"https://seekingalpha.com/news/2479906-analysts-defend-linkedin-amid-plunge-argue-non-ad-issues-are-temporary\" target=\"_blank\">defended</a> the company afterwards.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2554626\" data-linked=\"LinkedIn up 3.5% amid activist rumor, bullish RBC note\" data-tweet=\"$MSFT - LinkedIn up 3.5% amid activist rumor, bullish RBC note https://seekingalpha.com/news/2554626-linkedin-up-3_5-percent-amid-activist-rumor-bullish-rbc-note?source=tweet\" data-url=\"https://seekingalpha.com/news/2554626-linkedin-up-3_5-percent-amid-activist-rumor-bullish-rbc-note\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2554516\" data-ts=\"1433181427\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNOW\" target=\"_blank\">GNOW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2554516-american-caresource-up-73-percent-on-heavy-volume\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Caresource up 73% on heavy volume</a></h4><ul><li>Thinly traded nano cap American Caresource Holdings (ANCI <font color='green'>+72.9%</font>) skyrockets on a whopping 24x surge in volume. No particular news accounts for the action. Long-term stockholders are no doubt happy with the move regardless of the reason. Shares are still down over 90% from the November 2008 peak of $28.50.</li></ul><div class=\"tiny-share-widget\" data-id=\"2554516\" data-linked=\"American Caresource up 73% on heavy volume\" data-tweet=\"$GNOW - American Caresource up 73% on heavy volume https://seekingalpha.com/news/2554516-american-caresource-up-73-percent-on-heavy-volume?source=tweet\" data-url=\"https://seekingalpha.com/news/2554516-american-caresource-up-73-percent-on-heavy-volume\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2554476\" data-ts=\"1433180589\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMCI\" target=\"_blank\">SMCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2554476-super-micro-plus-6_1-percent-fund-manager-plugs-shares-on-cnbc\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Super Micro +6.1%; fund manager plugs shares on CNBC</a></h4><ul>\n<li>On CNBC this morning (<a href=\"http://finance.yahoo.com/video/top-3-portfolio-plays-pro-124200567.html\" target=\"_blank\">video</a>), Delphi Management's Scott Black named Super Micro (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SMCI\" title=\"Super Micro Computer, Inc.\">SMCI</a>) one of his top three picks. He predicts the modular server OEM will continue posting ~20% sales growth, and estimates shares are trading at 13x forward EPS after backing out stock compensation spend.</li>\n<li>Black: \"There are just not many 20% growers selling at 13 P/E.\" Super Micro's FQ4 (June quarter) consensus implies 26.1% Y/Y sales growth, while its FY16 (ends June '16) consensus implies 14.7% growth.</li>\n<li>Shares have rallied to their highest levels since mid-April, when they sold off in response to <a href=\"https://seekingalpha.com/news/2440396-super-micro-computer-slides-4_3-percent-on-earning-miss\" target=\"_blank\">a Q1 miss</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2554476\" data-linked=\"Super Micro +6.1%; fund manager plugs shares on CNBC\" data-tweet=\"$SMCI - Super Micro +6.1%; fund manager plugs shares on CNBC https://seekingalpha.com/news/2554476-super-micro-plus-6_1-percent-fund-manager-plugs-shares-on-cnbc?source=tweet\" data-url=\"https://seekingalpha.com/news/2554476-super-micro-plus-6_1-percent-fund-manager-plugs-shares-on-cnbc\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2554406\" data-ts=\"1433179278\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QUNR\" target=\"_blank\">QUNR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2554406-qunar-up-4_2-percent-ahead-of-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qunar up 4.2% ahead of earnings</a></h4><ul>\n<li>Qunar (NASDAQ:<a href=\"https://seekingalpha.com/symbol/QUNR\" title=\"Qunar Cayman Islands Limited\">QUNR</a>) is posting big gains ahead of this afternoon's Q1 report. 1.42M shares have been traded thus far, topping a 3-month daily average of 1.26M.</li>\n<li>The fast-growing Chinese online travel firm is <strong><font color=\"green\">up 59%</font></strong> since providing a big Q1 beat and strong Q2 guidance on March 16.  Shares recently pared their gains after archrival Ctrip announced <a href=\"https://seekingalpha.com/news/2541276-ctrip-plus-5_6-percent-after-400m-elong-stake-purchase-qunar-minus-4_5-percent\" target=\"_blank\">an investment</a> in eLong and received <a href=\"https://seekingalpha.com/news/2542776-priceline-increases-stake-in-ctrip\" target=\"_blank\">fresh funding</a> from Priceline.</li>\n<li>Also: SA author John Zhang recently wrote a pair of bearish columns (<a href=\"https://seekingalpha.com/article/3206516-baidus-control-over-qunar-poses-immense-risk-for-public-shareholders\" target=\"_blank\">I</a>, <a href=\"https://seekingalpha.com/article/3214726-qunar-overvalued-with-numerous-risks-and-skyrocketing-costs\" target=\"_blank\">II</a>), arguing (among other things) Qunar parent Baidu is prioritizing its own interests over those of Qunar shareholders. Jeff Cai <a href=\"https://seekingalpha.com/article/3218806-qunar-is-a-long-term-winner-in-the-chinese-travel-market\" target=\"_blank\">offered</a> a more bullish take.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2554406\" data-linked=\"Qunar up 4.2% ahead of earnings\" data-tweet=\"$QUNR - Qunar up 4.2% ahead of earnings https://seekingalpha.com/news/2554406-qunar-up-4_2-percent-ahead-of-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/2554406-qunar-up-4_2-percent-ahead-of-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2554266\" data-ts=\"1433177313\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2554266-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li>\n<b>Gainers:</b> ANCI <font color=\"green\">+39%</font>. <a href=\"https://seekingalpha.com/symbol/ESI-OLD\" title=\"ITT Educational Services Inc.\">ESI-OLD</a> <font color=\"green\">+31%</font>. <a href=\"https://seekingalpha.com/symbol/SPCB\" title=\"SuperCom, Ltd.\">SPCB</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/CCCR-OLD\" title=\"China Commercial Credit\">CCCR-OLD</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/TAOM\" title=\"Taomee Holdings\">TAOM</a> <font color=\"green\">+14%</font>. OGXI <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/BOOT\" title=\"Boot Barn Holdings\">BOOT</a> <font color=\"green\">+13%</font>. <a href=\"https://seekingalpha.com/symbol/CIA\" title=\"Citizens, Inc.\">CIA</a> <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/CCCL\" title=\"China Ceramics Co., Ltd.\">CCCL</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/PRAN\" title=\"Prana Biotechnology Ltd\">PRAN</a> <font color=\"green\">+10%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/TBIO\" title=\"Translate Bio\">TBIO</a> <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/HQCL\" title=\"Hanwha Q CELLS Co., Ltd.\">HQCL</a> <font color=\"red\">-15%</font>. PBMD <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/CZR\" title=\"Caesars Entertainment\">CZR</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/UWN\" title=\"Nevada Gold &amp; Casinos, Inc\">UWN</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/DATE\" title=\"Jiayuan.com International Ltd.\">DATE</a> <font color=\"red\">-13%</font>. <a href=\"https://seekingalpha.com/symbol/GSAT\" title=\"Globalstar, Inc.\">GSAT</a> <font color=\"red\">-11%</font>. <a href=\"https://seekingalpha.com/symbol/KIQ\" title=\"Kelso Technologies, Inc.\">KIQ</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/WG\" title=\"Willbros Group, Inc.\">WG</a> <font color=\"red\">-9%</font>. <a href=\"https://seekingalpha.com/symbol/VCO-OLD\" title=\"Vina Concha y Toro S.A. (ADR)\">VCO-OLD</a> <font color=\"red\">-9%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2554266\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$GNOW $ESI-OLD $SPCB - Midday Gainers / Losers https://seekingalpha.com/news/2554266-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/2554266-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2554246\" data-ts=\"1433176375\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HK\" target=\"_blank\">HK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2554246-halcon-resources-up-on-insider-buying-disclosure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Halcon Resources up on insider buying disclosure</a></h4><ul>     <li>Halcon Resources (<a href='https://seekingalpha.com/symbol/HK' title='Halcon Resources Corporation'>HK</a> <font color='green'>+2.8%</font>) is higher following the <a href=\"http://www.sec.gov/Archives/edgar/data/936305/000120919115048168/xslF345X01/doc4.xml\" target=\"_blank\">disclosure</a> that Chairman/CEO Floyd Wilson purchased 1M shares of he company's stock on the open market in transactions last Thursday and Friday.</li>     <li>The stock was purchased at an average cost of $1.03/share, with a total value of $1,03M; following the transaction, Wilson now directly owns nearly 4.75M HK shares valued at ~$4.9M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2554246\" data-linked=\"Halcon Resources up on insider buying disclosure\" data-tweet=\"$HK $HKRS - Halcon Resources up on insider buying disclosure https://seekingalpha.com/news/2554246-halcon-resources-up-on-insider-buying-disclosure?source=tweet\" data-url=\"https://seekingalpha.com/news/2554246-halcon-resources-up-on-insider-buying-disclosure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2554206\" data-ts=\"1433175365\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REGI\" target=\"_blank\">REGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2554206-renewable-energy-upgraded-by-piper-jaffray-after-new-epa-proposal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Renewable Energy upgraded by Piper Jaffray after new EPA proposal</a></h4><ul>     <li>Renewable Energy (<a href=\"https://seekingalpha.com/symbol/REGI\" title=\"Renewable Energy Group, Inc\">REGI</a> <font color=\"green\">+10.4%</font>) is <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/15/06/5555880/piper-jaffray-upgrades-renewable-energy-after-new-epa-pr\" target=\"_blank\">upgraded</a> to Overweight from Neutral with a $15 price target, raised from $11, at Piper Jaffray following <a href=\"https://seekingalpha.com/news/2551526-ethanol-stocks-outperform-as-epa-unveils-mandate\" target=\"_blank\">last week's release</a> of the EPA proposal of the renewable fuel standard mandate which the firm says removes the regulatory overhang that has historically impacted REGI shares.</li>     <li>Jaffray expects the increase proposed in the advanced biofuel category, along with the 20% carryover, to drive biodiesel demand \"beyond the biomass-based diesel RVO,\" which in turn should lead to higher margins for REGI, despite a potential increase in biodiesel imports.</li>\n<li>The firm also expects margins to be driven by higher RINs following the EPS proposal.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2554206\" data-linked=\"Renewable Energy upgraded by Piper Jaffray after new EPA proposal\" data-tweet=\"$REGI - Renewable Energy upgraded by Piper Jaffray after new EPA proposal https://seekingalpha.com/news/2554206-renewable-energy-upgraded-by-piper-jaffray-after-new-epa-proposal?source=tweet\" data-url=\"https://seekingalpha.com/news/2554206-renewable-energy-upgraded-by-piper-jaffray-after-new-epa-proposal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2554136\" data-ts=\"1433174457\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASUUY\" target=\"_blank\">ASUUY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2554136-pixelworks-up-13_5-percent-on-asus-video-processor-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pixelworks up 13.5% on Asus video processor deal</a></h4><ul>\n<li>Asus (<a href=\"https://seekingalpha.com/symbol/ASUUY\" title=\"ASUSTeK Computer Inc. ADR\">OTC:ASUUY</a>) is using Pixelworks' (NASDAQ:<a href=\"https://seekingalpha.com/symbol/PXLW\" title=\"Pixelworks, Inc.\">PXLW</a>) Iris mobile video processor in its new Hero ZenPad tablet. The companies appear to be referring to Asus' <a href=\"http://www.pocket-lint.com/news/134086-asus-zenpad-s-8-0-leads-series-update-offering-luxury-finish-stylus-support\" target=\"_blank\">ZenPad S 8.0</a>, an 8\" Android tablet that was unveiled this morning at the Computex trade show; it has a 2048x1536 resolution and quad-core Intel Atom CPU.</li>\n<li>Asus/Pixelworks also state the ZenPad is \"the world's first tablet to incorporate Pixelworks' True Clarity display enhancements,\" and claim True Clarity integration allows the device to provide blur-free video, cleaner/sharper images, and automatic lighting compensation.</li>\n<li>Pixelworks has surged to its highest levels since early March. <a href=\"https://seekingalpha.com/news/2476986-pixelworks-down-14-percent-on-q1-miss-soft-q2-guidance\" target=\"_blank\">The company stated</a> during its April 30 Q1 CC it had landed new Iris design wins; a second-gen version of the processor is expected to enter mass-production by year's end.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2554136\" data-linked=\"Pixelworks up 13.5% on Asus video processor deal\" data-tweet=\"$ASUUY $ASUUY $PXLW - Pixelworks up 13.5% on Asus video processor deal https://seekingalpha.com/news/2554136-pixelworks-up-13_5-percent-on-asus-video-processor-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/2554136-pixelworks-up-13_5-percent-on-asus-video-processor-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2554126\" data-ts=\"1433174349\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRP\" target=\"_blank\">TRP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2554126-transcanada-wins-deals-with-three-more-first-nations-for-proposed-pipeline\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TransCanada wins deals with three more First Nations for proposed pipeline</a></h4><ul>     <li>TransCanada (<a href=\"https://seekingalpha.com/symbol/TRP\" title=\"TransCanada Corporation\">TRP</a> <font color=\"red\">-1.8%</font>) says it has reached project agreements with three more First Nations in British Columbia as part of efforts to build the Prince Rupert Gas Transmission pipeline across the province to a proposed liquefied natural gas terminal on the coast.</li>     <li>TRP does not announce specifics but says they  <a href=\"http://business.financialpost.com/news/energy/transcanada-corp-reaches-deals-with-three-more-b-c-first-nations-for-proposed-lng-pipeline\" target=\"_blank\">provide for annual legacy payments</a> over the commercial life of the pipeline plus benefits upon signing and at other milestones.</li>     <li>TRP already had reached four other First Nations agreements but members of the Lax Kw\u2019alaams First Nation rejected a $1.15B offer from Petronas, which wants to build the Pacific Northwest LNG terminal on Lelu Island south of Prince Rupert.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2554126\" data-linked=\"TransCanada wins deals with three more First Nations for proposed pipeline\" data-tweet=\"$TRP - TransCanada wins deals with three more First Nations for proposed pipeline https://seekingalpha.com/news/2554126-transcanada-wins-deals-with-three-more-first-nations-for-proposed-pipeline?source=tweet\" data-url=\"https://seekingalpha.com/news/2554126-transcanada-wins-deals-with-three-more-first-nations-for-proposed-pipeline\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2554096\" data-ts=\"1433173588\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SINA\" target=\"_blank\">SINA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2554096-sina-plus-22_5-percent-weibo-plus-7_4-percent-sina-ceo-investing-456m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sina +22.5%, Weibo +7.4%; Sina CEO investing $456M</a></h4><ul>\n<li>\n<a href=\"https://seekingalpha.com/symbol/SINA\" title=\"Sina Corporation\">SINA</a> chairman/CEO Charles Chao plans to buy 11M newly-issued shares at $41.49 apiece (total cost of $456M). His purchase price is equal to Sina's 30-day average closing price as of May 29, and above a Friday close of $40.73.</li>\n<li>Chao's shares are subject to a 6-month lockup restriction. Sina had $2.1B in cash/short-term investments at the end of Q1, and $800M in convertible debt.</li>\n<li>Sina has soared to its highest levels since last summer, and has taken subsidiary Weibo higher with it.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2554096\" data-linked=\"Sina +22.5%, Weibo +7.4%; Sina CEO investing $456M\" data-tweet=\"$SINA - Sina +22.5%, Weibo +7.4%; Sina CEO investing $456M https://seekingalpha.com/news/2554096-sina-plus-22_5-percent-weibo-plus-7_4-percent-sina-ceo-investing-456m?source=tweet\" data-url=\"https://seekingalpha.com/news/2554096-sina-plus-22_5-percent-weibo-plus-7_4-percent-sina-ceo-investing-456m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2554016\" data-ts=\"1433173438\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRTX\" target=\"_blank\">MRTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2554016-mirati-therapeutics-drops-after-patients-treated-with-mgcd265-do-not-meet-recist-criteria-for-clinical-response\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mirati Therapeutics drops after patients treated with MGCD265 do not meet RECIST criteria for clinical response</a></h4><ul>\n<li>Thinly traded Mirati Therapeutics (<a href=\"https://seekingalpha.com/symbol/MRTX\" title=\"Mirati Therapeutics, Inc.\">MRTX</a> <font color=\"red\">-17.2%</font>) slumps on a 7x surge in volume in response to the presentation of an abstract (<a href=\"http://abstracts.asco.org/156/AbstView_156_146788.html\" target=\"_blank\">#2589</a>) at ASCO on a Phase 1 trial of its tyrosine kinase inhibitor, MGCD265, in heavily pretreated patients with non-small cell lung cancer (NSCLC) with <a href=\"http://ghr.nlm.nih.gov/gene/MET\" target=\"_blank\">MET gene</a> mutations.</li>\n<li>According to investigators, <a href=\"http://www.mirati.com/programs/mgcd265/\" target=\"_blank\">MGCD265 </a>showed anti-tumor activity and clinical benefit (improvements in pain and shortness of breath) in the first three patients treated, but none met RECIST criteria for responses, which is the metric used in clinical trials.</li>\n<li>\n<a href=\"http://en.wikipedia.org/wiki/Response_Evaluation_Criteria_in_Solid_Tumors\" target=\"_blank\">RECIST </a>(Response Evaluation Criteria in Solid Tumors) is a standardized method to measure the change in tumor burden.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2554016\" data-linked=\"Mirati Therapeutics drops after patients treated with MGCD265 do not meet RECIST criteria for clinical response\" data-tweet=\"$MRTX - Mirati Therapeutics drops after patients treated with MGCD265 do not meet RECIST criteria for clinical response https://seekingalpha.com/news/2554016-mirati-therapeutics-drops-after-patients-treated-with-mgcd265-do-not-meet-recist-criteria-for-clinical-response?source=tweet\" data-url=\"https://seekingalpha.com/news/2554016-mirati-therapeutics-drops-after-patients-treated-with-mgcd265-do-not-meet-recist-criteria-for-clinical-response\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2554056\" data-ts=\"1433172976\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BYD\" target=\"_blank\">BYD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2554056-boyd-gaming-higher-after-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boyd Gaming higher after upgrade</a></h4><ul> <li>Credit Suisse walked away from a meeting with Boyd Gaming's (<a href=\"https://seekingalpha.com/symbol/BYD\" title=\"Boyd Gaming Corporation\">BYD</a> <font color=\"green\">+2.9%</font>) top brass confident the casino operator can show <a href=\"http://www.analystratings.net/stocks/NYSE/BYD/\" target=\"_blank\">improved results</a> in Las Vegas and Atlantic City.</li>\n<li>Boyd trades only slight below its 52-week high.</li>  <li>CS has Boyd rated at Outperform with a $18 price target.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"2554056\" data-linked=\"Boyd Gaming higher after upgrade\" data-tweet=\"$BYD - Boyd Gaming higher after upgrade https://seekingalpha.com/news/2554056-boyd-gaming-higher-after-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/2554056-boyd-gaming-higher-after-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553996\" data-ts=\"1433171301\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OUT\" target=\"_blank\">OUT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553996-outfront-media-launches-in-house-creative-unit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Outfront Media launches in-house creative unit</a></h4><ul>    <li>Out-of-home advertising firm Outfront Media (NYSE:<a href=\"https://seekingalpha.com/symbol/OUT\" title=\"Outfront Media, Inc.\">OUT</a>) is <font color=\"green\">up 2%</font> after the launch of its in-house boutique, Outfront Studios, charged with designing campaigns for its clients internally.</li>    <li>One of the unit's first designs was an award-winner for Georgia Tech athletics.</li>    <li>The design team will develop display advertising in consultation with clients using Outfront's proprietary research.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2553996\" data-linked=\"Outfront Media launches in-house creative unit\" data-tweet=\"$OUT - Outfront Media launches in-house creative unit https://seekingalpha.com/news/2553996-outfront-media-launches-in-house-creative-unit?source=tweet\" data-url=\"https://seekingalpha.com/news/2553996-outfront-media-launches-in-house-creative-unit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553956\" data-ts=\"1433170692\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBBY\" target=\"_blank\">BBBY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553956-bed-bath-and-beyond-higher-on-chatter-of-activist-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bed Bath &amp; Beyond higher on chatter of activist stake</a></h4><ul> <li>Bed Bath &amp; Beyond (<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a> <font color='green'>+1.2%</font>) spikes on strong volume after speculation of an <a href=\"https://twitter.com/OpenOutcrier/status/605386045102817280\" target=\"_blank\">activist stake</a> by Jana Partners starts to make the rounds.</li> <li>Shares of BBBY are back over $72 for the first time in two weeks.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"2553956\" data-linked=\"Bed Bath &amp; Beyond higher on chatter of activist stake\" data-tweet=\"$BBBY - Bed Bath &amp; Beyond higher on chatter of activist stake https://seekingalpha.com/news/2553956-bed-bath-and-beyond-higher-on-chatter-of-activist-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/2553956-bed-bath-and-beyond-higher-on-chatter-of-activist-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553926\" data-ts=\"1433169931\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RXDX\" target=\"_blank\">RXDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553926-ignyta-up-34-percent-on-encouraging-results-for-entrectinib\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ignyta up 34% on encouraging results for entrectinib</a></h4><ul>\n<li>Thinly traded small cap Ignyta (<a href=\"https://seekingalpha.com/symbol/RXDX\" title=\"Ignyta, Inc.\">RXDX</a> <font color=\"green\">+33.7%</font>) jumps on a 10x surge in volume in response to poster presentations (abstracts <a href=\"http://abstracts.asco.org/156/AbstView_156_150911.html\" target=\"_blank\">#2596</a> and <a href=\"http://abstracts.asco.org/156/AbstView_156_149995.html\" target=\"_blank\">#2517</a>) at ASCO on two Phase 1 studies of <a href=\"http://ignyta.com/technology/\" target=\"_blank\">entrectinib</a>, the company's proprietary oral tyrosine kinase inhibitor. One of the objectives was to determine the optimal dose of entrectinib for a Phase 2 trial in patients with certain mutation-positive tumors.</li>\n<li>Encouraging efficacy was also observed, however. In 11 patients who would meet the anticipated eligibility criteria for the planned Phase 2, 10 showed clinical activity demonstrating a preliminary response rate of 91% (n=10/11).</li>\n<li>\n<a href=\"http://en.wikipedia.org/wiki/Tyrosine_kinase\" target=\"_blank\">Tyrosine kinase</a> is an enzyme that serves as an \"on/off\" switch in many cellular functions. If stuck in the \"on\" position, unregulated cell growth occurs.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2553926\" data-linked=\"Ignyta up 34% on encouraging results for entrectinib\" data-tweet=\"$RXDX - Ignyta up 34% on encouraging results for entrectinib https://seekingalpha.com/news/2553926-ignyta-up-34-percent-on-encouraging-results-for-entrectinib?source=tweet\" data-url=\"https://seekingalpha.com/news/2553926-ignyta-up-34-percent-on-encouraging-results-for-entrectinib\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553916\" data-ts=\"1433169824\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPH\" target=\"_blank\">TPH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553916-tri-pointe-homes-plus-3_75-percent-as-it-finds-a-sell-side-fan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TRI Pointe Homes +3.75% as it finds a sell-side fan</a></h4><ul>\n<li>\"We think TRI Pointe Homes (<a href=\"https://seekingalpha.com/symbol/TPH\" title=\"TRI Pointe Group, Inc.\">TPH</a> <font color=\"green\">+3.7%</font>) is making good progress integrating its WRECO acquisition from 2014, and we expect this will be the primary driver of earnings in an improving housing environment,\" says FBR's Patrick Kealey, <a href=\"http://www.streetinsider.com/Analyst+Comments/FBR+Capital+Upgrades+TRI+Pointe+Homes+%28TPH%29+to+Outperform/10610219.html\" target=\"_blank\">upgrading to Outperform</a> and lifting the price target by $1 to $17. \"We believe higher volumes, coupled with its unique land portfolio, should give TPH the ability to grow longterm operating margins faster than competitors.\"</li>\n<li>The market, however, is not pricing in this potential as the stock trades at a valuation discount to peers, says Kealey. Continued execution over time should narrow the gap, he says.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2553916\" data-linked=\"TRI Pointe Homes +3.75% as it finds a sell-side fan\" data-tweet=\"$TPH - TRI Pointe Homes +3.75% as it finds a sell-side fan https://seekingalpha.com/news/2553916-tri-pointe-homes-plus-3_75-percent-as-it-finds-a-sell-side-fan?source=tweet\" data-url=\"https://seekingalpha.com/news/2553916-tri-pointe-homes-plus-3_75-percent-as-it-finds-a-sell-side-fan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553886\" data-ts=\"1433169557\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WELL\" target=\"_blank\">WELL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553886-health-care-reit-higher-after-evercore-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Health Care REIT higher after Evercore upgrade</a></h4><ul><li>Health Care REIT (HCN <font color='green'>+1.1%</font>) is an outlier to the upside among the seniors housing and healthcare names <a href=\"http://www.streetinsider.com/Upgrades/Evercore+ISI+Upgrades+Health+Care+REIT+%28HCN%29+to+Buy/10610272.html\" target=\"_blank\">after being upgraded</a> to Buy at Evercore ISI.</li></ul><div class=\"tiny-share-widget\" data-id=\"2553886\" data-linked=\"Health Care REIT higher after Evercore upgrade\" data-tweet=\"$WELL - Health Care REIT higher after Evercore upgrade https://seekingalpha.com/news/2553886-health-care-reit-higher-after-evercore-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/2553886-health-care-reit-higher-after-evercore-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553876\" data-ts=\"1433169443\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKNG\" target=\"_blank\">BKNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553876-homeaway-plus-5_3-percent-pricelines-kayak-unit-to-show-vacation-rentals\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HomeAway +5.3%; Priceline&#39;s Kayak unit to show vacation rentals</a></h4><ul>\n<li>Priceline's (PCLN <font color=\"red\">-0.2%</font>) Kayak travel search engine <a href=\"http://finance.yahoo.com/news/kayak-display-homeaway-inc-vacation-120427435.html\" target=\"_blank\">will now include</a> nearly 200K HomeAway (NASDAQ:<a href=\"https://seekingalpha.com/symbol/AWAY\" title=\"HomeAway, Inc.\">AWAY</a>) vacation rental listings. The deal is expected to go live by year's end.</li>\n<li>The companies state travelers will be able to \"search and find vacation rentals on KAYAK just as they would a hotel and complete their reservation on the HomeAway site where the property is listed.\" Kayak currently shows over 700K hotel listings.</li>\n<li>Priceline hasn't broken out Kayak's sales since acquiring the company in 2013. Priceline did state on its Q4 CC (<a href=\"https://seekingalpha.com/article/2934426-priceline-group-inc-pcln-ceo-darren-huston-on-q4-2014-results-earnings-call-transcript\" target=\"_blank\">transcript</a>) Kayak delivered \"strong top-line results and bottom-line results significantly [exceeding] our expectations at the time of acquisition\" in 2014.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2553876\" data-linked=\"HomeAway +5.3%; Priceline&#39;s Kayak unit to show vacation rentals\" data-tweet=\"$BKNG $BKNG $AWAY - HomeAway +5.3%; Priceline&#39;s Kayak unit to show vacation rentals https://seekingalpha.com/news/2553876-homeaway-plus-5_3-percent-pricelines-kayak-unit-to-show-vacation-rentals?source=tweet\" data-url=\"https://seekingalpha.com/news/2553876-homeaway-plus-5_3-percent-pricelines-kayak-unit-to-show-vacation-rentals\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553746\" data-ts=\"1433168007\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTIC\" target=\"_blank\">CTIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553746-cti-biopharma-up-18-percent-on-positive-results-for-pacritinib-in-rare-blood-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CTI BioPharma up 18% on positive results for pacritinib in rare blood cancer</a></h4><ul>\n<li>CTI BioPharma (<a href=\"https://seekingalpha.com/symbol/CTIC\" title=\"CTI BioPharma Corp.\">CTIC</a> <font color=\"green\">+17.5%</font>) jumps in early trading in response to its announcement at ASCO (abstract #<a href=\"http://abstracts.asco.org/156/AbstView_156_150526.html\" target=\"_blank\">LBA7006</a>) that patients with myelofibrosis treated with its lead product candidate, <a href=\"http://www.ctibiopharma.com/pipeline/pacritinib/\" target=\"_blank\">pacritinib</a>, in a Phase 3 trial called PERSIST-1 met the primary efficacy endpoint of a statistically significant reduction in spleen volume compared to baseline at week 24. The results were originally reported in March.</li>\n<li>Fast Track-designated pacritinib, an oral tyrosine kinase inhibitor, is being co-developed with Baxter International (<a href=\"https://seekingalpha.com/symbol/BAX\" title=\"Baxter International Inc\">BAX</a> <font color=\"red\">-0.2%</font>). <a href=\"http://en.wikipedia.org/wiki/Tyrosine_kinase\" target=\"_blank\">Tyrosine kinase</a> is an enzyme that serves as an \"on/off\" switch in many cellular functions. If stuck in the \"on\" position, unregulated cell growth occurs.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2353856-cti-bio-up-19-percent-premarket-on-phase-3-results\" target=\"_blank\">CTI Bio up 19% premarket on Phase 3 results</a> (March 9)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2553746\" data-linked=\"CTI BioPharma up 18% on positive results for pacritinib in rare blood cancer\" data-tweet=\"$CTIC $CTIC $BAX - CTI BioPharma up 18% on positive results for pacritinib in rare blood cancer https://seekingalpha.com/news/2553746-cti-biopharma-up-18-percent-on-positive-results-for-pacritinib-in-rare-blood-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/2553746-cti-biopharma-up-18-percent-on-positive-results-for-pacritinib-in-rare-blood-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553826\" data-ts=\"1433167873\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNPR\" target=\"_blank\">JNPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553826-juniper-minus-3-percent-mkm-downgrades-cites-carrier-technology-trends\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Juniper -3%; MKM downgrades, cites carrier technology trends</a></h4><ul>\n<li>Believing the bull case for the company is based on \"faulty assumptions\" that ignore major changes in carrier router usage, MKM's Michael Genovese has downgraded Juniper (NYSE:<a href=\"https://seekingalpha.com/symbol/JNPR\" title=\"Juniper Networks\">JNPR</a>) to Sell, while keeping its target at $22.</li>\n<li>Specifically, Genovese argues tier-1 carriers appear committed to \"\"a multi-step network transition that includes fewer Routing nodes (more Optical nodes) and aggressive Router pricing demands near-term,\" and that they eventually want to \"deploy more multi-purpose, standardized hardware and to open-up the network software to be more multi-vendor and programmable\" (i.e. adopt <a href=\"http://en.wikipedia.org/wiki/Software-defined_networking\" target=\"_blank\">SDN</a> and <a href=\"http://en.wikipedia.org/wiki/Network_functions_virtualization\" target=\"_blank\">NFV</a>). Juniper client AT&amp;T is among the carriers embracing the latter trend, via its <a href=\"https://seekingalpha.com/news/1486171-mkm-sees-at-and-t-project-hurting-cisco-helping-vmware-ciena-f5-finisar\" target=\"_blank\">Domain 2.0</a> initiative.</li>\n<li>Genovese also believes 2H15 consensus estimates - they assume rebounding telecom capex - are too high, and that Juniper is unlikely to be acquired by a larger vendor. Speculation about an Ericsson bid has been <a href=\"https://seekingalpha.com/news/2544906-ericsson-now-open-to-big-m-and-a\" target=\"_blank\">running high</a> since the Nokia/Alcatel-Lucent deal.</li>\n<li>Shares remain <font color=\"green\">up 21%</font> YTD. They trade for 16x 2015E EPS.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2553826\" data-linked=\"Juniper -3%; MKM downgrades, cites carrier technology trends\" data-tweet=\"$JNPR - Juniper -3%; MKM downgrades, cites carrier technology trends https://seekingalpha.com/news/2553826-juniper-minus-3-percent-mkm-downgrades-cites-carrier-technology-trends?source=tweet\" data-url=\"https://seekingalpha.com/news/2553826-juniper-minus-3-percent-mkm-downgrades-cites-carrier-technology-trends\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553816\" data-ts=\"1433167734\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553816-treasury-prices-slide-after-national-pmi-heads-higher\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Treasury prices slide after national PMI heads higher</a></h4><ul>\n<li>The <a href=\"https://seekingalpha.com/news/2553786-ism-manufacturing-rises-to-52_8\" target=\"_blank\">Manufacturing ISM headline PMI</a> rose to 52.8 in May from April's 51.5. Forecasts called for a gain to 52.0. The solid print is especially notable given the <a href=\"https://seekingalpha.com/news/2551326-q2-rebound-chicago-pmi-tumbles-in-may\" target=\"_blank\">unexpected dive</a> in the Chicago PMI (reported on Friday).</li>\n<li>New Orders rose to 55.8 from 53.5. Production slipped to 54.5 from 56. Employment 51.7 vs. 48.3. Supplier Deliveries 50.7 vs. 50.1. Backlogs 53.5 vs. 49.5.</li>\n<li>Prices jumped to 49.5 from 40.5.</li>\n<li>At 2.12% ahead of the number, the 10-year Treasury yield jumps to 2.16%, up three basis points on the session. <a href=\"https://seekingalpha.com/symbol/tlt\" title=\"iShares 20+ Year Treasury Bond ETF\">TLT</a> <font color=\"red\">-0.8%</font>, <a href=\"https://seekingalpha.com/symbol/tbt\" title=\"ProShares UltraShort 20+ Year Treasury ETF\">TBT</a> <font color=\"green\">+1.6%</font>\n</li>\n<li>ETFs: <a href=\"https://seekingalpha.com/symbol/tbt\" title=\"ProShares UltraShort 20+ Year Treasury ETF\">TBT</a>, <a href=\"https://seekingalpha.com/symbol/tlt\" title=\"iShares 20+ Year Treasury Bond ETF\">TLT</a>, <a href=\"https://seekingalpha.com/symbol/tmv\" title=\"Direxion Daily 20+ Year Treasury Bear 3x Shares ETF\">TMV</a>, <a href=\"https://seekingalpha.com/symbol/tbf\" title=\"ProShares Short 20+ Year Treasury ETF\">TBF</a>, <a href=\"https://seekingalpha.com/symbol/edv\" title=\"Vanguard Extended Duration Treasury ETF\">EDV</a>, <a href=\"https://seekingalpha.com/symbol/tmf\" title=\"Direxion Daily 30-Year Treasury Bull 3x Shares ETF\">TMF</a>, <a href=\"https://seekingalpha.com/symbol/ttt\" title=\"ProShares UltraPro Short 20+ Year Treasury ETF\">TTT</a>, <a href=\"https://seekingalpha.com/symbol/zroz\" title=\"PIMCO 25+ Year Zero Coupon U.S. Treasury Index ETF\">ZROZ</a>, <a href=\"https://seekingalpha.com/symbol/tlh\" title=\"iShares 10-20 Year Treasury Bond ETF\">TLH</a>, <a href=\"https://seekingalpha.com/symbol/sbnd\" title=\"PowerShares DB 3x Short 25+ Year Treasury Bond ETN\">SBND</a>, <a href=\"https://seekingalpha.com/symbol/vglt\" title=\"Vanguard Long-Term Government Bond Index ETF\">VGLT</a>, <a href=\"https://seekingalpha.com/symbol/ubt\" title=\"ProShares Ultra 20+ Year Treasury ETF\">UBT</a>, <a href=\"https://seekingalpha.com/symbol/dlbs\" title=\"iPath U.S. Treasury Long Bond Bear ETN\">DLBS</a>, <a href=\"https://seekingalpha.com/symbol/tlo\" title=\"SPDR Barclays Long Term Treasury ETF\">TLO</a>, <a href=\"https://seekingalpha.com/symbol/tenz\" title=\"PIMCO 7-15 Year U.S. Treasury Index ETF\">TENZ</a>, <a href=\"https://seekingalpha.com/symbol/lbnd\" title=\"PowerShares DB 3x Long 25+ Year Treasury Bond ETN\">LBND</a>, <a href=\"https://seekingalpha.com/symbol/dlbl\" title=\"iPath U.S. Treasury Long Bond Bull ETN\">DLBL</a>, <a href=\"https://seekingalpha.com/symbol/tybs\" title=\"Direxion Daily 20+ Year Treasury Bear 1x ETF\">TYBS</a>, <a href=\"https://seekingalpha.com/symbol/vustx\" title=\"Vanguard Long Term Treasury Fund Inv\">VUSTX</a>\n</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2553816\" data-linked=\"Treasury prices slide after national PMI heads higher\" data-tweet=\"$TLT $TBT $TMV - Treasury prices slide after national PMI heads higher https://seekingalpha.com/news/2553816-treasury-prices-slide-after-national-pmi-heads-higher?source=tweet\" data-url=\"https://seekingalpha.com/news/2553816-treasury-prices-slide-after-national-pmi-heads-higher\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553806\" data-ts=\"1433167518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMC\" target=\"_blank\">AMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553806-theater-chains-receive-doj-request-for-documents\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Theater chains receive DOJ request for documents</a></h4><ul> <li>Exhibitor stocks are skittish after the Department of Justice asks several chains for more <a href=\"http://deadline.com/2015/06/justice-department-amc-entertainment-antitrust-investigation-1201435467/\" target=\"_blank\">documents</a> relating to an anti-trust probe of the industry.</li> <li>The larger theater chains have been accused of using clearance agreements to pressure studios away from using small and independent chains.</li> <li>The matter hasn't been escalated to a full DOJ investigation yet.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2434146-movie-exclusivity-deals-with-theater-chains-on-the-doj-radar\" target=\"_blank\">Movie exclusivity deals with theater chains on the DOJ radar</a> (Apr. 17 2015)</li> <li>Decliners: AMC Entertainment (NYSE:<a href=\"https://seekingalpha.com/symbol/AMC\" title=\"AMC Entertainment Holdings, Inc\">AMC</a>) <font color=\"red\">-4.4%</font>, Carmike Cinemas (NASDAQ:<a href=\"https://seekingalpha.com/symbol/CKEC\" title=\"Carmike Cinemas, Inc.\">CKEC</a>) <font color=\"red\">-1.0%</font>, Cinemark Holdings (NYSE:<a href=\"https://seekingalpha.com/symbol/CNK\" title=\"Cinemark Holdings, Inc\">CNK</a>) <font color=\"red\">-0.4%</font>, Regal Entertainment (NYSE:<a href=\"https://seekingalpha.com/symbol/RGC\" title=\"Regal Entertainment Group\">RGC</a>) <font color=\"red\">-0.2%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2553806\" data-linked=\"Theater chains receive DOJ request for documents\" data-tweet=\"$AMC $AMC $CKEC - Theater chains receive DOJ request for documents https://seekingalpha.com/news/2553806-theater-chains-receive-doj-request-for-documents?source=tweet\" data-url=\"https://seekingalpha.com/news/2553806-theater-chains-receive-doj-request-for-documents\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553756\" data-ts=\"1433166958\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMCN\" target=\"_blank\">AMCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553756-airmedia-group-rallies-after-winning-wi-fi-train-contract-in-beijing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AirMedia Group rallies after winning Wi-Fi train contract in Beijing</a></h4><ul> <li>AirMedia Group (<a href=\"https://seekingalpha.com/symbol/AMCN\" title=\"AirMedia Group Inc\">AMCN</a> <font color=\"green\">+8.2%</font>) jumps after one of the company's Chinese entities landed the Wi-Fi rights for some trains run in Beijing.</li> <li>The contract covers 89 ordinary trains run by the Beijing Railway Bureau.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2553756\" data-linked=\"AirMedia Group rallies after winning Wi-Fi train contract in Beijing\" data-tweet=\"$AMCN $ANTE - AirMedia Group rallies after winning Wi-Fi train contract in Beijing https://seekingalpha.com/news/2553756-airmedia-group-rallies-after-winning-wi-fi-train-contract-in-beijing?source=tweet\" data-url=\"https://seekingalpha.com/news/2553756-airmedia-group-rallies-after-winning-wi-fi-train-contract-in-beijing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553706\" data-ts=\"1433166533\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMGN\" target=\"_blank\">IMGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553706-immunogen-gaps-up-49-percent-on-positive-results-in-difficult-to-treat-ovarian-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ImmunoGen gaps up 49% on positive results in difficult-to-treat ovarian cancer</a></h4><ul>\n<li>ImmunoGen (<a href=\"https://seekingalpha.com/symbol/IMGN\" title=\"ImmunoGen, Inc.\">IMGN</a> <font color=\"green\">+49%</font>) jumps out of the gate this morning in response to its announcement of positive results in a Phase 1 dose ranging trial assessing its <a href=\"http://www.immunogen.com/adc-defined\" target=\"_blank\">antibody-drug conjugate</a>, IMGN853 (<a href=\"http://www.immunogen.com/imgn853\" target=\"_blank\">mirvetuximab soravtansine</a>), in patients with folate-receptor alpha-positive platinum-resistant ovarian cancer, a difficult-to-treat type with typical response rates of less than 20%.</li>\n<li>The overall response rate was 53% (n=9/17) which included one complete response and eight partial responses. Responses in six of the nine patients were ongoing at the time of data cutoff, with five of the six on treatment for more than 15 weeks. The data were presented as ASCO (abstract <a href=\"http://abstracts.asco.org/156/AbstView_156_150531.html\" target=\"_blank\">#5558</a>).</li>\n<li>The company plans to initiate a Phase 2 study later this year that may support a New Drug Application (NDA) filing.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2553706\" data-linked=\"ImmunoGen gaps up 49% on positive results in difficult-to-treat ovarian cancer\" data-tweet=\"$IMGN - ImmunoGen gaps up 49% on positive results in difficult-to-treat ovarian cancer https://seekingalpha.com/news/2553706-immunogen-gaps-up-49-percent-on-positive-results-in-difficult-to-treat-ovarian-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/2553706-immunogen-gaps-up-49-percent-on-positive-results-in-difficult-to-treat-ovarian-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553606\" data-ts=\"1433165277\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/POST\" target=\"_blank\">POST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553606-post-holdings-plus-3-percent-after-wells-fargo-turns-optimistic\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post Holdings +3% after Wells Fargo turns optimistic</a></h4><ul> <li>Wells Fargo <a href=\"http://www.streetinsider.com/Hot+Upgrades/Wells+Fargo+Upgrades+Post+Holdings+%28POST%29+to+Outperform/10611348.html\" target=\"_blank\">upgrades</a> Post Holdings (NYSE:<a href=\"https://seekingalpha.com/symbol/POST\" title=\"Post Holdings, Inc.\">POST</a>) to an Outperform rating from Market Perform.</li> <li>Shares of Post Holdings fell 7.8% in May as concerns on the impact of the avian flu in the Midwest increased.</li> <li>POST <font color=\"green\">+3.42%</font> premarket to $44.74.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2553606\" data-linked=\"Post Holdings +3% after Wells Fargo turns optimistic\" data-tweet=\"$POST - Post Holdings +3% after Wells Fargo turns optimistic https://seekingalpha.com/news/2553606-post-holdings-plus-3-percent-after-wells-fargo-turns-optimistic?source=tweet\" data-url=\"https://seekingalpha.com/news/2553606-post-holdings-plus-3-percent-after-wells-fargo-turns-optimistic\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553586\" data-ts=\"1433164928\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXEL\" target=\"_blank\">EXEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553586-exelixis-up-10-percent-premarket-on-successful-lung-cancer-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Exelixis up 10% premarket on successful lung cancer study</a></h4><ul>\n<li>Exelixis (NASDAQ:<a href=\"https://seekingalpha.com/symbol/EXEL\" title=\"Exelixis, Inc.\">EXEL</a>) is up <font color=\"green\">10%</font> premarket on robust volume in response to its announcement of positive results from a Phase 2 clinical trial, Study E1512, assessing <a href=\"http://www.exelixis.com/pipeline/GDC_0973_xl518\" target=\"_blank\">cabozantinib </a> (<a href=\"http://www.cometriq.com/about/\" target=\"_blank\">Cometriq</a>) for the treatment of EGFR wild-type non-small cell lung cancer (NSCLC).</li>\n<li>The study met its primary endpoint of a statistically significant increase in progression-free survival (PFS) in patients treated with cabozantinib and the combination of cabozantinib plus Roche's <a href=\"http://www.tarceva.com/patient/\" target=\"_blank\">Tarceva </a>(erlotinib) compared to patients treated with erlotinib alone. PFS for the cabozantinib monotherapy cohort was 4.2 months versus 1.9 months for erlotinib alone (p=0.0004). PFS for the cabozantinib + erlotinib was 4.7 months (p=0.0005).</li>\n<li>Overall survival, a secondary endpoint, for the three arms was 9.2 months, 13.3 months and 4.1 months, respectively (p=0.004).</li>\n<li>Most patients had a rough go of it, though. Grade 3 (severe) or higher (life threatening) adverse events were 67% in the cabozantinib mono arm, 72% in the combo arm compared to 35% in the erlotinib arm.</li>\n<li>Cabozantinib</li>\n<li>The data will be presented today (abstract #8003) at ASCO.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2553586\" data-linked=\"Exelixis up 10% premarket on successful lung cancer study\" data-tweet=\"$EXEL - Exelixis up 10% premarket on successful lung cancer study https://seekingalpha.com/news/2553586-exelixis-up-10-percent-premarket-on-successful-lung-cancer-study?source=tweet\" data-url=\"https://seekingalpha.com/news/2553586-exelixis-up-10-percent-premarket-on-successful-lung-cancer-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553576\" data-ts=\"1433164860\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553576-premarket-gainers-losers-as-of-9-15-am\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:15 am</a></h4><ul> <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/OMG\" title=\"OM Group, Inc.\">OMG</a> <font color=\"green\">+28%</font>. ONTY <font color=\"green\">+27%</font>. <a href=\"https://seekingalpha.com/symbol/IMGN\" title=\"ImmunoGen, Inc.\">IMGN</a> <font color=\"green\">+26%</font>. <a href=\"https://seekingalpha.com/symbol/PRAN\" title=\"Prana Biotechnology Ltd\">PRAN</a> <font color=\"green\">+20%</font>. <a href=\"https://seekingalpha.com/symbol/RXDX\" title=\"Ignyta, Inc.\">RXDX</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/ESI-OLD\" title=\"ITT Educational Services Inc.\">ESI-OLD</a> <font color=\"green\">+18%</font>. CLDN <font color=\"green\">+12%</font>. OXGN <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/EXEL\" title=\"Exelixis, Inc.\">EXEL</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/IMMU\" title=\"Immunomedics, Inc.\">IMMU</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/HRTX\" title=\"Heron Therapeutics, Inc.\">HRTX</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/TGTX\" title=\"TG Therapeutics, Inc.\">TGTX</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/VBLT\" title=\"VBL Therapeutics\">VBLT</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/ALTR\" title=\"Altair Engineering, Inc.  Cl A\">ALTR</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/SYN\" title=\"Synthetic Biologics, Inc.\">SYN</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/CTIC\" title=\"CTI BioPharma Corp.\">CTIC</a> <font color=\"green\">+6%</font>. <a href=\"https://seekingalpha.com/symbol/KITE\" title=\"Kite Pharma\">KITE</a> <font color=\"green\">+5%</font>.</li>     <li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/CLVS\" title=\"Clovis Oncology\">CLVS</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/DCTH\" title=\"Delcath Systems, Inc.\">OTC:DCTH</a> <font color=\"red\">-4%</font>. <a href=\"https://seekingalpha.com/symbol/ATNM\" title=\"Actinium Pharmaceuticals, Inc.\">ATNM</a> <font color=\"red\">-6%</font>. PTBI <font color=\"red\">-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2553576\" data-linked=\"Premarket Gainers / Losers as of 9:15 am\" data-tweet=\"$OMG $CASC $IMGN - Premarket Gainers / Losers as of 9:15 am https://seekingalpha.com/news/2553576-premarket-gainers-losers-as-of-9-15-am?source=tweet\" data-url=\"https://seekingalpha.com/news/2553576-premarket-gainers-losers-as-of-9-15-am\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553566\" data-ts=\"1433164796\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HERO\" target=\"_blank\">HERO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553566-saudi-aramco-withdraws-termination-notice-for-hercules-offshore-rig\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Saudi Aramco withdraws termination notice for Hercules Offshore rig</a></h4><ul>     <li>Hercules Offshore (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HERO\" title=\"Hercules Offshore Inc\">HERO</a>) <font color=\"green\">+9%</font> premarket after announcing that Saudi Aramco withdrew its notice of termination for its Hercules 261 oil rig and that all terms and conditions of the contract remain in full force and effect for the remainder of the five-year term of the  contract.</li>\n<li>However, HERO says it expects the dayrates on the rig, as well as the Hercules 262 and the Hercules 266 which  are also under contract with Saudi Aramco, to be  significantly reduced to bring the rates in line with current market  rates for similarly-classed rigs in the region.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2553566\" data-linked=\"Saudi Aramco withdraws termination notice for Hercules Offshore rig\" data-tweet=\"$HERO $HEROQ - Saudi Aramco withdraws termination notice for Hercules Offshore rig https://seekingalpha.com/news/2553566-saudi-aramco-withdraws-termination-notice-for-hercules-offshore-rig?source=tweet\" data-url=\"https://seekingalpha.com/news/2553566-saudi-aramco-withdraws-termination-notice-for-hercules-offshore-rig\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553536\" data-ts=\"1433164290\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UPS\" target=\"_blank\">UPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553536-ups-on-the-move-after-barrons-calls-out-potential\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UPS on the move after Barron&#39;s calls out potential</a></h4><ul> <li>Shares of UPS (NYSE:<a href=\"https://seekingalpha.com/symbol/UPS\" title=\"United Parcel Service, Inc.\">UPS</a>) are higher in early trading after a <a href=\"http://online.barrons.com/articles/ups-shares-ready-to-deliver-1432956062?mod=BOL_hp_highlight_2\" target=\"_blank\">favorable writeup</a> in <i>Barron's</i> provides a lift.</li> <li>It's noted UPS improved its yield per package in Q1 and trades below its typical premium over the S&amp;P P/E ratio.</li> <li>The potential for UPS to grow margins with its online business as it works out some growing pains and the +3% yield also make UPS look attractive to the <em>Barron's</em> crew.</li> <li>UPS <font color=\"green\">+1.30%</font> to $100.52.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2553536\" data-linked=\"UPS on the move after Barron&#39;s calls out potential\" data-tweet=\"$UPS - UPS on the move after Barron&#39;s calls out potential https://seekingalpha.com/news/2553536-ups-on-the-move-after-barrons-calls-out-potential?source=tweet\" data-url=\"https://seekingalpha.com/news/2553536-ups-on-the-move-after-barrons-calls-out-potential\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553356\" data-ts=\"1433163403\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VBLT\" target=\"_blank\">VBLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553356-vascular-biogenics-up-11-percent-premarket-on-positive-results-for-lead-product-candidate-in-brain-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vascular Biogenics up 11% premarket on positive results for lead product candidate in brain cancer</a></h4><ul>\n<li>Micro cap Vascular Biogenics (NASDAQ:<a href=\"https://seekingalpha.com/symbol/VBLT\" title=\"VBL Therapeutics\">VBLT</a>) is up <font color=\"green\">11%</font> premarket on robust volume in response to its <a href=\"http://ir.vblrx.com/phoenix.zhtml?c=253311&amp;p=irol-newsArticle&amp;ID=2054895\" target=\"_blank\">announcement </a>of positive interim results from a Phase 2 study assessing its lead product candidate, <a href=\"http://www.vblrx.com/cancer-programs/cancer-pipline/\" target=\"_blank\">VB-111</a>, in patients with <a href=\"http://www.medscape.com/viewarticle/540150\" target=\"_blank\">recurrent glioblastoma</a> (rGBM), one of the most aggressive primary brain tumors. The data showed a statistically significant benefit in overall survival (OS) in patients treated with VB-111 followed by VB-111 in combination with Roche's (<a href=\"https://seekingalpha.com/symbol/RHHBY\" title=\"Roche Holding Ltd ADR\">OTCQX:RHHBY</a>) <a href=\"http://www.avastin.com/patient\" target=\"_blank\">Avastin </a>(bevacizumab) upon disease progression compared to patients treated with VB-111 followed by bevacizumab alone (p=0.05). The full results were presented earlier this morning at a meeting for investors in conjunction with ASCO.</li>\n<li>46 patients with rGBM were treated with VB-111. Upon disease progression, 23 were treated with VB-111 + bevacizumab and 22 received bevacizumab alone (one patient was stable on VB-111 alone after 18 months). Median OS in the combination arm was 16 months compared to eight months in the bevacizumab alone arm (p=0.05).</li>\n<li>VB-111 is an <a href=\"http://en.wikipedia.org/wiki/Angiogenesis_inhibitor\" target=\"_blank\">anti-angiogenic</a> agent which is designed to restrict tumor growth by inhibiting the proliferation of new blood vessels that form to support rapidly growing cells.</li>\n<li>The company intends to initiate a Phase 3 trial later this year.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2553356\" data-linked=\"Vascular Biogenics up 11% premarket on positive results for lead product candidate in brain cancer\" data-tweet=\"$VBLT $VBLT $RHHBY - Vascular Biogenics up 11% premarket on positive results for lead product candidate in brain cancer https://seekingalpha.com/news/2553356-vascular-biogenics-up-11-percent-premarket-on-positive-results-for-lead-product-candidate-in-brain-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/2553356-vascular-biogenics-up-11-percent-premarket-on-positive-results-for-lead-product-candidate-in-brain-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553426\" data-ts=\"1433162948\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553426-intel-confirms-altera-purchase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intel confirms Altera purchase</a></h4><ul>\n<li>As rumored over the weekend, Intel (NASDAQ:<a href=\"https://seekingalpha.com/symbol/INTC\" title=\"Intel Corporation\">INTC</a>) agrees to buy Altera (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ALTR\" title=\"Altair Engineering, Inc.  Cl A\">ALTR</a>) for $54 per share in cash, or $16.7B. The purchase is expected to be accretive to Intel's EPS and free cash flow in the first year after the close (in six-to-nine months).</li>\n<li>A <a href=\"http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.intc.com&amp;esheet=51114363&amp;newsitemid=20150601005864&amp;lan=en-US&amp;anchor=www.intc.com&amp;index=2&amp;md5=261f62d15758de6c73ef7e6ec6f9418f\" target=\"_blank\">webcast </a>to discuss the deal is set for 10 ET.</li>\n<li>INTC <font color=\"green\">+0.65%</font> and ALTR <font color=\"green\">+4.8%</font> (to $51.20) premarket</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2552826-wsj-intel-to-announce-54-share-altera-deal-on-monday\" target=\"_blank\">WSJ: Intel to announce $54/share Altera deal on Monday</a> (May 31)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2553426\" data-linked=\"Intel confirms Altera purchase\" data-tweet=\"$INTC - Intel confirms Altera purchase https://seekingalpha.com/news/2553426-intel-confirms-altera-purchase?source=tweet\" data-url=\"https://seekingalpha.com/news/2553426-intel-confirms-altera-purchase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553316\" data-ts=\"1433160919\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACAT\" target=\"_blank\">ACAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553316-arctic-cat-minus-2-percent-after-bmo-capital-warns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arctic Cat -2% after BMO Capital warns</a></h4><ul> <li>Shares of Arctic Cat (NASDAQ:<a href='https://seekingalpha.com/symbol/ACAT' title='Arctic Cat Inc.'>ACAT</a>) slip in early trading after BMO Capital <a href=\"https://twitter.com/RatingsNetwork/status/605335871915732992\" target=\"_blank\">shifts</a> its rating to Underperform from Market Perform.</li> <li>BMO thinks valuation on Arctic has outrun the earnings potential of the snowmobile seller.</li> <li>ACAT <font color='red'>-1.96%</font> to $32.43.</li> </ul><div class=\"tiny-share-widget\" data-id=\"2553316\" data-linked=\"Arctic Cat -2% after BMO Capital warns\" data-tweet=\"$ACAT - Arctic Cat -2% after BMO Capital warns https://seekingalpha.com/news/2553316-arctic-cat-minus-2-percent-after-bmo-capital-warns?source=tweet\" data-url=\"https://seekingalpha.com/news/2553316-arctic-cat-minus-2-percent-after-bmo-capital-warns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553276\" data-ts=\"1433160186\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/C\" target=\"_blank\">C</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553276-citigroup-higher-after-goldman-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citigroup higher after Goldman upgrade</a></h4><ul>\n<li>Citigroup (NYSE:<a href=\"https://seekingalpha.com/symbol/C\" title=\"Citigroup Inc.\">C</a>) is trading cheaper than 96% of S&amp;P 500 companies on an EPS basis, says Goldman Sachs, <a href=\"http://www.streetinsider.com/Hot+Upgrades/Goldman+Sachs+Upgrades+Citi+%28C%29+to+Buy/10610226.html\" target=\"_blank\">upgrading</a> to a Buy (h/t <a href=\"https://twitter.com/amberkanwar/status/605342876793483264\" target=\"_blank\">BNN's Amber Kanwar</a>)</li>\n<li>Shares <font color=\"green\">+1.4%</font> premarket</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2553276\" data-linked=\"Citigroup higher after Goldman upgrade\" data-tweet=\"$C - Citigroup higher after Goldman upgrade https://seekingalpha.com/news/2553276-citigroup-higher-after-goldman-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/2553276-citigroup-higher-after-goldman-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553266\" data-ts=\"1433159938\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPY\" target=\"_blank\">SPY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553266-futures-turn-higher-on-rumor-of-greek-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Futures turn higher on rumor of Greek deal</a></h4><ul><li>Today's \"Greece is fixed\" rumor has S&amp;P 500 (NYSEARCA:<a href='https://seekingalpha.com/symbol/SPY' title='SPDR S&P 500 Trust ETF'>SPY</a>) futures&nbsp;<font color='green'>ahead by 0.45%</font>&nbsp;vs. flat just a few minutes ago.</li></ul><div class=\"tiny-share-widget\" data-id=\"2553266\" data-linked=\"Futures turn higher on rumor of Greek deal\" data-tweet=\"$SPY - Futures turn higher on rumor of Greek deal https://seekingalpha.com/news/2553266-futures-turn-higher-on-rumor-of-greek-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/2553266-futures-turn-higher-on-rumor-of-greek-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553226\" data-ts=\"1433159219\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CASC\" target=\"_blank\">CASC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553226-oncothyreon-up-46-percent-premarket-on-ontminus-380-study-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oncothyreon up 46% premarket on ONT-380 study results</a></h4><ul>\n<li>Small cap Oncothyreon (ONTY) is up <font color=\"green\">46%</font> premarket on robust volume in response to its announcement at ASCO of positive data from a Phase 1b <a href=\"https://clinicaltrials.gov/ct2/show/NCT02025192?term=NCT02025192&amp;rank=1\" target=\"_blank\">clinical trial</a> evaluating its lead product candidate, <a href=\"http://www.oncothyreon.com/product_pipeline/ont-380.html\" target=\"_blank\">ONT-380</a>, in combination with Roche's <a href=\"http://www.gene.com/download/pdf/xeloda_prescribing.pdf\" target=\"_blank\">Xeloda </a>(capecitabine) and <a href=\"http://www.herceptin.com/\" target=\"_blank\">Herceptin </a>(trastuzumab), as third line treatment of patients with HER-positive metastatic breast cancer. The trial was a dose escalation study in patients previously treated with Herceptin and <a href=\"http://www.kadcyla.com/\" target=\"_blank\">Kadcyla </a>(ado-trastuzumab emtansine).</li>\n<li>The disease control rate in 27 evaluable patients in all three cohorts combined (ONT-380 + Xeloda; ONT-380 + Herceptin; ONT-380 + Xeloda + Herceptin) was 85% (n=23/27). Specifically, two patients had a complete response, 12 showed a partial response and nine showed stable disease. Four patients progressed.</li>\n<li>Results from another <a href=\"https://clinicaltrials.gov/ct2/show/NCT01983501?term=NCT01983501&amp;rank=1\" target=\"_blank\">Phase 1b study</a> assessing ONT-380 in patients with metastatic breast cancer with central nervous system (CNS) metastases showed a 64% disease control rate (n=14/22) (one complete response, four partial responses and nine with stable disease). No patient had progressive disease as a CNS best response.</li>\n<li>ONT-380 was well tolerated in both studies. Most adverse events were either grade 1 or 2.</li>\n<li>The company intends to advance ONT-380 to Phase 2 development later this year.</li>\n<li>Previously: <a href=\"https://seekingalpha.com/news/2524216-asco-abstract-stoked-investors-bid-up-oncothyreon\" target=\"_blank\">ASCO abstract-stoked investors bid up Oncothyreon</a> (May 14)</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2553226\" data-linked=\"Oncothyreon up 46% premarket on ONT-380 study results\" data-tweet=\"$CASC - Oncothyreon up 46% premarket on ONT-380 study results https://seekingalpha.com/news/2553226-oncothyreon-up-46-percent-premarket-on-ontminus-380-study-results?source=tweet\" data-url=\"https://seekingalpha.com/news/2553226-oncothyreon-up-46-percent-premarket-on-ontminus-380-study-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"2553206\" data-ts=\"1433158754\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCPIQ\" target=\"_blank\">MCPIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/2553206-wsj-molycorp-expected-to-skip-loan-payment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ: Molycorp expected to skip loan payment</a></h4><ul>\n<li>Molycorp (MCP) is expected to announce it will <a href=\"http://www.wsj.com/articles/molycorp-struggles-to-survive-rare-earths-bubble-1433110948\" target=\"_blank\">skip a $32.5M loan payment</a>,  triggering a 30-day grace period that could lead to a bankruptcy filing  before the end of June, <em>WSJ</em> reports.</li>\n<li>MCP has suffered three straight years of quarterly losses, has  $1.7B in debt, and has been able to generate only slightly more than half its goal of producing 20K metric tons/year  at its Mountain Pass, Calif., rare earths mine.</li>\n<li>MCP <font color=\"red\">-24.4%</font> premarket.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"2553206\" data-linked=\"WSJ: Molycorp expected to skip loan payment\" data-tweet=\"$MCPIQ - WSJ: Molycorp expected to skip loan payment https://seekingalpha.com/news/2553206-wsj-molycorp-expected-to-skip-loan-payment?source=tweet\" data-url=\"https://seekingalpha.com/news/2553206-wsj-molycorp-expected-to-skip-loan-payment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":52,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}